U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231003) titled 'The Effect of Glucomannan Powder on Improving Gut Microbiota.' on Nov. 13.
Brief Summary: The object of this study is evaluating the effects of the Glucommanan on the healthy human subjects who are. In this trial, at most 30 healthy subjects whose ages are 20~65 years old (15 for placebo and 15 for intervention)will be included. The total experiment will be 9 weeks and the intervention period will be 6 weeks, within which, at week 0, 6, and 7, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), aspartate aminotransferase (AST, also known as GOT), alan...